https://orcid.org/0000-0002-2643-3184
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Manisha Gurnani, Abhishek Chauhan, Anuj Ranjan, Priyanka Gopi, Arabinda Ghosh, Hardeep Singh Tuli, Shafiul Haque, Prateek Pandya, Rup Lal & Tanu Jindal. (2023) Cyanobacterial compound Tolyporphine K as an inhibitor of Apo-PBP (penicillin-binding protein) in A. baumannii and its ADME assessment. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Read now
Articles from other publishers (20)
Reza Khoshbakht, Susan Panahi, Alireza Neshani, Mahdis Ghavidel & Kiarash Ghazvini. (2023) Novel approaches to overcome Colistin resistance in Acinetobacter baumannii: Exploring quorum quenching as a potential solution. Microbial Pathogenesis 182, pages 106264.
Crossref
Crossref
Jeongwoo JoJi Young LeeHongbaek ChoKwan Soo Ko. (2023)
Treatment of Colistin Dependence-Developing
Acinetobacter baumannii
with Antibiotic Combinations at Subinhibitory Concentrations
. Microbial Drug Resistance.
Crossref
Crossref
Katarina Novović & Branko Jovčić. (2023) Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology. Antibiotics 12:3, pages 516.
Crossref
Crossref
Sheng-Huei Wang, Kuang-Yao Yang, Chau-Chyun Sheu, Yu-Chao Lin, Ming-Cheng Chan, Jia-Yih Feng, Chia-Min Chen, Chih-Yu Chen, Zhe-Rong Zheng, Yu-Ching Chou & Chung-Kan Peng. (2023) The prevalence, presentation and outcome of colistin susceptible-only Acinetobacter Baumannii-associated pneumonia in intensive care unit: a multicenter observational study. Scientific Reports 13:1.
Crossref
Crossref
Go Kamoshida, Noriteru Yamada, Tomoka Nakamura, Daiki Yamaguchi, Daichi Kai, Maho Yamashita, Chiaki Hayashi, Nana Kanda, Moe Sakaguchi, Hitoshi Morimoto, Teppei Sawada, Tomoko Okada, Yuki Kaya, Norihiko Takemoto & Kinnosuke Yahiro. (2022) Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii. Microbiology Spectrum 10:5.
Crossref
Crossref
Ping Wang, Hongou Wang, Cunwei Liu, Chengjie Feng, Qinghui Lu & Qinghua Zou. (2022) Fitness Costs of Tigecycline Resistance in Acinetobacter baumannii and the Resistance Mechanism Revealed by a Transposon Mutation Library. Antibiotics 11:10, pages 1379.
Crossref
Crossref
Michelle Lowe, Ashika Singh-Moodley, Husna Ismail, Teena Thomas, Vindana Chibabhai, Trusha Nana, Warren Lowman, Arshad Ismail, Wai Yin Chan & Olga Perovic. (2022) Molecular characterisation of Acinetobacter baumannii isolates from bloodstream infections in a tertiary-level hospital in South Africa. Frontiers in Microbiology 13.
Crossref
Crossref
Stamatis Karakonstantis, Petros Ioannou & Diamantis D. Kofteridis. (2022) In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations. Infection 50:3, pages 569-581.
Crossref
Crossref
Stamatis Karakonstantis, Maria Rousaki & Evangelos I. Kritsotakis. (2022) Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance. Antibiotics 11:6, pages 723.
Crossref
Crossref
Noel-David Nogbou, Mbudzeni Ramashia, Granny Marumo Nkawane, Mushal Allam, Chikwelu Lawrence Obi & Andrew Munyalo Musyoki. (2022) Whole-Genome Sequencing of a Colistin-Resistant Acinetobacter baumannii Strain Isolated at a Tertiary Health Facility in Pretoria, South Africa. Antibiotics 11:5, pages 594.
Crossref
Crossref
Mohammad Al-Tamimi, Hadeel Albalawi, Mohamd Alkhawaldeh, Abdullah Alazzam, Hassan Ramadan, Majd Altalalwah, Ahmad Alma’aitah, Dua’a Al Balawi, Sharif Shalabi, Jumana Abu-Raideh, Ashraf I. Khasawneh, Farah Alhaj & Kamal Hijawi. (2022) Multidrug-Resistant Acinetobacter baumannii in Jordan. Microorganisms 10:5, pages 849.
Crossref
Crossref
Jiangang Zhang, Jinru Xie, Henan Li, Zhiren Wang, Yuyao Yin, Shuyi Wang, Hongbin Chen, Qi Wang & Hui Wang. (2022) Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients. Microbiology Spectrum 10:1.
Crossref
Crossref
Federica Sacco, Camilla Bitossi, Bruno Casciaro, Maria Rosa Loffredo, Guendalina Fabiano, Luisa Torrini, Flavia Raponi, Giammarco Raponi & Maria Luisa Mangoni. (2022) The Antimicrobial Peptide Esc(1-21) Synergizes with Colistin in Inhibiting the Growth and in Killing Multidrug Resistant Acinetobacter baumannii Strains. Antibiotics 11:2, pages 234.
Crossref
Crossref
Stamatis Karakonstantis & Evangelos I. Kritsotakis. (2021) Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex. Infection 49:6, pages 1149-1161.
Crossref
Crossref
Jeongwoo Jo & Kwan Soo Ko. (2021) Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii. Microbiology Spectrum 9:2.
Crossref
Crossref
Ling Yang, Ning Dong, Chen Xu, Lianwei Ye & Sheng Chen. (2021) Emergence of ST63 Pandrug-Resistant Acinetobacter pittii Isolated From an AECOPD Patient in China. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Corneliu Ovidiu Vrancianu, Elena Georgiana Dobre, Irina Gheorghe, Ilda Barbu, Roxana Elena Cristian & Mariana Carmen Chifiriuc. (2021) Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections. Microorganisms 9:4, pages 730.
Crossref
Crossref
Meysam Sarshar, Payam Behzadi, Daniela Scribano, Anna Teresa Palamara & Cecilia Ambrosi. (2021) Acinetobacter baumannii: An Ancient Commensal with Weapons of a Pathogen. Pathogens 10:4, pages 387.
Crossref
Crossref
Stamatis Karakonstantis, Evangelos I Kritsotakis & Achilleas Gikas. (2020) Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. Infection 48:6, pages 835-851.
Crossref
Crossref
Stamatis Karakonstantis & Ioannis Saridakis. (2020) Colistin heteroresistance in Acinetobacter spp.: systematic review and meta-analysis of the prevalence and discussion of the mechanisms and potential therapeutic implications. International Journal of Antimicrobial Agents 56:2, pages 106065.
Crossref
Crossref